A preliminary study of 18F-FES PET/CT in predicting metastatic breast cancer in patients receiving docetaxel or fulvestrant with docetaxel

QR Code

A preliminary study of 18F-FES PET/CT in predicting metastatic breast cancer in patients receiving docetaxel or fulvestrant with docetaxel

Abstract The present explorative study was initiated to evaluate the clinical value of 18F-FES PET/CT in monitoring the change of estrogen receptor (ER) expression and potential predictive value in metastatic breast cancer patients. Twenty-two pathology-confirmed breast cancer patients were prospect...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Chengcheng Gong, Zhongyi Yang, Yifei Sun, Jian Zhang, Chunlei Zheng, Leiping Wang, Yongping Zhang, Jing Xue, Zhifeng Yao, Herong Pan, Biyun Wang, Yingjian Zhang
Format:	article
Langue:	EN
Publié:	Nature Portfolio 2017
Sujets:	Medicine R Science Q
Accès en ligne:	https://doaj.org/article/5f858afef231473483d6e91ca47f4bd9
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Prognostic Value of Tumor Heterogeneity on 18F-FDG PET/CT in HR+HER2− Metastatic Breast Cancer Patients receiving 500 mg Fulvestrant: a retrospective study
par: Yannan Zhao, et autres
Publié: (2018)

How nanotechnology can enhance docetaxel therapy
par: Zhang L, et autres
Publié: (2013)

Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant
par: Jill M. Spoerke, et autres
Publié: (2016)

Functionalized docetaxel-loaded lipid-based-nanosuspensions to enhance antitumor efficacy in vivo
par: Pang X, et autres
Publié: (2019)

Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy
par: Wang L, et autres
Publié: (2012)

Prognostic role of docetaxel-induced suppression of free testosterone serum levels in metastatic prostate cancer patients
par: Paula Kappler, et autres
Publié: (2021)

Therapeutic options in docetaxel-refractory metastatic castration-resistant prostate cancer: a cost-effectiveness analysis.
par: Lixian Zhong, et autres
Publié: (2013)

Core shell lipid-polymer hybrid nanoparticles with combined docetaxel and molecular targeted therapy for the treatment of metastatic prostate cancer
par: Qi Wang, et autres
Publié: (2017)

Impact of Serum γ-Glutamyltransferase on Overall Survival in Men with Metastatic Castration-Resistant Prostate Cancer Treated with Docetaxel
par: Minami Une, et autres
Publié: (2021)

Investigating the crucial roles of aliphatic tails in disulfide bond-linked docetaxel prodrug nanoassemblies
par: Yuequan Wang, et autres
Publié: (2021)

NC-6301, a polymeric micelle rationally optimized for effective release of docetaxel, is potent but is less toxic than native docetaxel in vivo
par: Harada M, et autres
Publié: (2012)

A novel lipid-based nanomicelle of docetaxel: evaluation of antitumor activity and biodistribution
par: Ma M, et autres
Publié: (2012)

Multifunctional gold nanorods and docetaxel-encapsulated liposomes for combined thermo- and chemotherapy
par: Hua H, et autres
Publié: (2017)

Docetaxel-loaded multilayer nanoparticles with nanodroplets for cancer therapy
par: Oh KS, et autres
Publié: (2016)

Docetaxel treatment in the elderly patient with hormone refractory prostate cancer
par: Victoria J Sinibaldi
Publié: (2008)

In vitro and in vivo evaluation of folate receptor-targeting amphiphilic copolymer-modified liposomes loaded with docetaxel
par: Li X, et autres
Publié: (2011)

Anti-Cancer Activity Based on the High Docetaxel Loaded Poly(2-Oxazoline)s Micelles
par: Xu M, et autres
Publié: (2021)

Synergistic enhancement of cancer therapy using a combination of docetaxel and photothermal ablation induced by single-walled carbon nanotubes
par: Zhang ZZ, et autres
Publié: (2011)

Docetaxel-associated myalgia–arthralgia syndrome in patients with breast cancer
par: Seguin C, et autres
Publié: (2017)

The influence of bile salt on the chemotherapeutic response of docetaxel-loaded thermosensitive nanomicelles
par: Kim DW, et autres
Publié: (2014)

Probiotics for the Treatment of Docetaxel-Related Weight Gain of Breast Cancer Patients—A Single-Center, Randomized, Double-Blind, and Placebo-Controlled Trial
par: Zhang Juan, et autres
Publié: (2021)

Antitumor activity of docetaxel-loaded polymeric nanoparticles fabricated by Shirasu porous glass membrane-emulsification technique
par: Yu YN, et autres
Publié: (2013)

Anti-Cancer Activity Based on the High Docetaxel Loaded Poly(2-Oxazoline)s Micelles [Corrigendum]
par: Xu M, et autres
Publié: (2021)

Co-Delivery of Docetaxel and Curcumin via Nanomicelles for Enhancing Anti-Ovarian Cancer Treatment
par: Hu Y, et autres
Publié: (2020)

Intravenous microemulsion of docetaxel containing an anti-tumor synergistic ingredient (Brucea javanica oil): formulation and pharmacokinetics
par: Ma S, et autres
Publié: (2013)

Phase II trail of nab-paclitaxel in metastatic breast cancer patients with visceral metastases
par: Yizhao Xie, et autres
Publié: (2021)

An effective strategy for development of docetaxel encapsulated gold nanoformulations for treatment of prostate cancer
par: S. Thambiraj, et autres
Publié: (2021)

Advancements in the oral delivery of Docetaxel: challenges, current state-of-the-art and future trends
par: Sohail MF, et autres
Publié: (2018)

Targeted Treatment of Colon Cancer with Aptamer-Guided Albumin Nanoparticles Loaded with Docetaxel
par: Yu Z, et autres
Publié: (2020)

Enhanced oral bioavailability of docetaxel by lecithin nanoparticles: preparation, in vitro, and in vivo evaluation
par: Hu K, et autres
Publié: (2012)

Docetaxel-titanate nanotubes enhance radiosensitivity in an androgen-independent prostate cancer model
par: C Mirjolet, et autres
Publié: (2017)

Comparative Treatment Patterns and Outcomes of Fulvestrant versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience
par: Li Y, et autres
Publié: (2020)

A prospective phase-II trial of biweekly docetaxel plus androgen deprivation therapy in patients with previously-untreated metastatic castration-naïve prostate cancer
par: Seonggyu Byeon, et autres
Publié: (2021)

Comparative study analyzing survival and safety of bevacizumab/carboplatin/paclitaxel versus carboplatin/docetaxel in initial treatment of metastatic Her-2-negative breast cancer
par: Abdel Kader Y, et autres
Publié: (2013)

Fulvestrant in Combination with CDK4/6 Inhibitors for HER2- Metastatic Breast Cancers: Current Perspectives
par: Iorfida M, et autres
Publié: (2020)

Pharmacokinetics and Toxicities of Oral Docetaxel Formulations Co-Administered with Ritonavir in Phase I Trials
par: Vermunt M, et autres
Publié: (2021)

Nanoparticulated docetaxel exerts enhanced anticancer efficacy and overcomes existing limitations of traditional drugs
par: Choi J, et autres
Publié: (2015)

Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile
par: Rafiei P, et autres
Publié: (2017)

Novel docetaxel-loaded nanoparticles based on PCL-Tween 80 copolymer for cancer treatment
par: Mei L, et autres
Publié: (2011)

Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts
par: Miguel Martin, et autres
Publié: (2021)